As of 2025-09-15, the EV/EBITDA ratio of Asensus Surgical Inc (ASXC) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASXC's latest enterprise value is 87.93 mil USD. ASXC's TTM EBITDA according to its financial statements is -75.08 mil USD. Dividing these 2 quantities gives us the above ASXC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 23.8x | 21.0x |
| Forward P/E multiples | 22.5x - 26.1x | 22.8x |
| Fair Price | (6.15) - (6.53) | (5.99) |
| Upside | -1869.1% - -1978.2% | -1822.8% |
| Date | EV/EBITDA |